IGF-1 results: why age and clinical context matter

A result needs a clinical question

IGF-1 is often presented as an optimization score, with a youthful target implying a better outcome. Clinical interpretation is more demanding. The useful question is why the test was ordered, which reference interval applies and what finding would change an appropriate decision. A higher result is not inherently a better result, and an age-related difference is not by itself a diagnosis of adult growth hormone deficiency.

What specialist guidance says

The Endocrine Society’s hypopituitarism guideline recommends stimulation testing for suspected growth hormone deficiency and notes that single GH measurements are not helpful. It also advises against GH administration to elderly adults with age-adjusted low IGF-1 but no hypothalamic or pituitary disease. That is guidance about clinical diagnosis and GH replacement; it is not a blanket endorsement or dosing framework for consumer sermorelin programs.

Why the reference interval matters

An assay result should be read using its own laboratory method and appropriate reference information. Compare like with like when reviewing repeat measurements, and tell the clinician about concurrent treatments and relevant medical conditions. A value can be real without explaining a symptom. Ask the ordering professional to distinguish an out-of-range result, an expected age-related pattern and evidence that warrants more focused evaluation.

A trial uses a marker differently

In the Vitiello sermorelin study, investigators monitored IGF-1 under a defined research protocol. Such monitoring can document biological response while the trial separately measures outcomes. It does not establish that someone outside the study should pursue the same numerical change. A research threshold used to manage an experiment is not automatically a validated target for wellness, performance or symptom relief in routine practice.

What to ask at a consultation

Ask whether the concern is a suspected endocrine disorder, a symptom needing a broader evaluation or a discretionary wellness goal. Request the rationale for each proposed test and what the possible results would change. If the explanation relies on restoring a young-adult value, ask for evidence that this target improves the particular outcome. The number should support clinical reasoning rather than replace it.

Ask for an explanation you can keep

At a visit, request the result with units, reference interval, collection date and the clinician’s interpretation. A standalone screenshot of a number is less useful when reviewing changes later. The explanation should say whether the finding is expected, uncertain or relevant to further assessment, and identify the reason for any next step.

A trend should also remain connected to the original clinical concern. If a repeat value rises while the person’s daily problem does not improve, the consultation should acknowledge the mismatch. Chasing a numerical target can consume time and money while leaving the reason for seeking care unresolved. A good monitoring discussion makes room for that conclusion instead of assuming every upward movement supports continued treatment.

Keep tracking connected to outcomes

Repeated testing can become expensive if no action rule or meaningful goal was established. A follow-up should review symptoms, adverse effects, daily function and treatment burden as well as any selected laboratory results. A rising marker with no worthwhile improvement may leave the original problem unresolved. Our service-cost planner keeps testing charges explicit; it cannot decide whether a test or prescription is indicated for you.